Intervention

Aminohippurate Sodium Inj 20%

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 7 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials7

Recruiting1

Common conditions25

Lead sponsors shown2

Clinical trials

7 shown

Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)NCT05008276 · 2021-09-27

RECRUITING

Renal Mechanism of SGLT2 InhibitionNCT05507892 · 2022-10-10

ACTIVE_NOT_RECRUITING

Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up StudyNCT05530356 · 2022-09-30

COMPLETED

Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin ResistanceNCT04074668 · 2020-01-01

COMPLETED

Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 DiabetesNCT03620773 · 2018-10-01

COMPLETED

Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes StudyNCT03584217 · 2018-10-01

ACTIVE_NOT_RECRUITING

Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic FunctionNCT03618420 · 2018-10-01

COMPLETED

Common conditions

Leading sponsors

University of Colorado, Denver 6 Petter Bjornstad 1

Trial status mix

COMPLETED4

ACTIVE_NOT_RECRUITING2

RECRUITING1

Phase mix

PHASE24

PHASE13

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.